biliary tract cancer
FDA Grants Accelerated Approval to Ziihera for Some People With Biliary Tract Cancer
The FDA granted accelerated approval to zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals), a bispecific ...
NOVEMBER 25, 2024
FDA Approves Keytruda With Chemotherapy for Biliary Tract Cancer
The FDA approved pembrolizumab (Keytruda, Merck) to be used with gemcitabine and cisplatin for locally advanced, ...
NOVEMBER 1, 2023
Progress Shown in Digestive Tract Cancer Treatments
Four new trials presented at ASCO 2023 may help change the way several GI cancers are treated.
OCTOBER 9, 2023
LAT1 Inhibitor Improves PFS in Refractory Biliary Tract Cancer
A LAT1 inhibitor, nanvuranlat (J-Pharma), significantly increased progression-free survival (PFS) rates among ...
FEBRUARY 22, 2023
Antibiotics Can Be Used During Durvalumab Treatment in Biliary Tract Cancer
Antibiotics can be administered without compromising treatment efficacy in patients receiving a durvalumab-based ...
FEBRUARY 20, 2023
Imfinzi Plus Chemotherapy Approved as First Immunotherapy Regimen for Advanced Biliary Tract Cancer
The FDA approved durvalumab (Imfinzi, AstraZeneca) for the treatment of adult patients with locally advanced or ...
SEPTEMBER 6, 2022
